Vaxart (VXRT) Shares Outstanding (Diluted) (2009 - 2026)
Vaxart's Shares Outstanding (Diluted) came in at 242.18 million for Q2 2026, up 6.3% from 227.92 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
For FY2025, Vaxart's Shares Outstanding (Diluted) was 230.35 million, up 14.0% from FY2024.
- Shares Outstanding (Diluted) carries a five-year compound annual growth rate of 99.4% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 202.14 million in FY2024, 7.3 million in FY2023 (unchanged), 7.3 million in FY2022 (unchanged) and 7.3 million in FY2021 (unchanged).
- Year-over-year, Shares Outstanding (Diluted) has increased for three consecutive quarters, with growth averaging 6.6% over the last four quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (Q3 2021) to 14.0% (Q4 2025).
- Business Quant data shows VXRT's Shares Outstanding (Diluted) at 242.18 million (Q1 2026), 230.35 million (Q4 2025) and 227.92 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Vaxart | 87.73 Mn | 22.23 Mn | - | 242.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 242.18 Mn |
| Jun 30, 2026 | 242.18 Mn |
| Mar 31, 2026 | 242.18 Mn |
| Dec 31, 2025 | 230.35 Mn |
| Sep 30, 2025 | 227.92 Mn |
| Jun 30, 2025 | 227.92 Mn |
| Mar 31, 2025 | 227.92 Mn |
| Dec 31, 2024 | 202.14 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 7.30 Mn |
| Sep 30, 2023 | 7.30 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 7.30 Mn |
| Dec 31, 2022 | 7.30 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.30 Mn |
API Access
Vaxart Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();